Throw in the cash and NOL's on the books and to me this is worth minimum $5-$7 per share. I will pile in if this hits $2.50ish. Overall market will dictate how far it will fall.
Share, very insightful comments. Are you a buyer at these levels or is this a stay away from stock for now? TY
TY. I agree, I would like to see open market purchases like we saw last summer....not that it helped. Really went to show how confident they were on Rintega.
Always love reading these Form 4's. Did Catlin exercise the options and then sell? Table 1 says he acquired 15,000 at $2.80 and then Table 2 has 15,000 in the disposed column. He still owns 50,739. Thoughts? Max
Buy some stock in the firm if they really believe in the other 6 programs. Options are meaningless to us investors. Put up or shut time.
Your an #$%$
Dark day not only for shareholders but patients of this terrible disease. So many signs pointed to a drug that worked. Bio is a crazy world. Never did I think this drug would fail. The 2 year survival rate was 25% vs. 0 in control arm. Where to next? No idea. May be worth taking a flier at below three. Think at some point BMY buys them at 5-6 per share.
AF is a tool in every sense. He knows nothing and works for his HF friends who pay him to write ill about stocks.
They may not end the trial early but they sure as hell know it will be approved. Why else do you think they are ramping up commercial operations? If stopped early, you are looking at a $8-$12 price jump immediately. If not, the haircut is maybe a buck. Anything more, and I am adding to my position.